SOPHiA GENETICSTM Myeloid Solution

Characterize key biomarkers with our comprehensive research application covering 30 genes associated with myelo- dysplastic syndromes, myeloproliferative neoplasms, and leukemia. This all-in-one solution enables assessment of DNA alterations aligned with key guidelines, including challenging genes (CALR, CEBPA, ASXL1, FLT3, including internal tandem duplications).

Want to learn more?

One of our experts will be in touch with you shortly!
This field is for validation purposes and should be left unchanged.

Enabling precise characterization of blood cancer driver genes by targeting relevant DNA variants and RNA fusion genes from blood or bone marrow samples.